Uttar Pradesh government planned to open Six Pharma Parks

Six Pharma Parks has been planned to set-up in the Uttar Pradesh state as the state has been received an investment commitment of about Rs 5,000-6,000 crore from domestic and multinational pharma companies.

Sidharth Nath Singh, Uttar Pradesh health minister said that the conversation is going with several big multinational companies like Mylan, GE, Pfizer and Sanofi with our domestic companies for setting up pharma units in the state. He also added that state already contributing 30% in the pharma manufacturing and exports of medicinal goods. New pharma policy had announced around three months back and have already received an investment commitment of about Rs 5,000-6,000 crore, of which we can hope that several will materialize soon.

Sidharth Nath Singh also said during his speech at the annual celebration event, the sidelines of the Organisation of Pharmaceutical Producers of India (OPPI), the parks have been planned to set up in Noida, Bundelkhand, Ghaziabad, Gorakhpur, Lucknow, and Allahabad, which will help in achieving faster growth.

He also announced that the state government will allot 100 to 250 acres of land and offer incentives like free electricity, zero stamp duty, an interest-free loan up to Rs 10 crore for the infrastructure development.

He also added that government also reimbursing for five to seven years the state GST component. The government planned to give capital intensive subsidy in the form of reimbursement to 60 percent (up to Rs 50 lakh for the maximum unit) for the R&D support. The state also offers a single window system and follow ethical practices.

Singh also highlighted that Centre’s Ayushman Bharat is a big initiative and programme and our initiative will be the backbone of implementing this. He also added the achievements of the state like state government has already reached out to 1,000 private and public hospitals and is reaching out to 1,000 more.

Singh also said that the government already running a huge training programme for the ASHA, ANMs and Anganwadi workers in the state to speed up the training process.

Related Posts

Piramal, Ajinomoto team on ADC development and manufacturing

Piramal Pharma Solutions, a global contract development and manufacturing organization, and Ajinomoto Bio-Pharma Services announced a strategic collaboration to support development and manufacturing of antibody-drug conjugates (ADCs) using AJICAP technology…

Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

New Delhi: Aurobindo Pharma Ltd on Friday said it has received final approval from the US health regulator to manufacture and market its generic version of glycerol phenylbutyrate oral liquid…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Piramal, Ajinomoto team on ADC development and manufacturing

Piramal, Ajinomoto team on ADC development and manufacturing

Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

Cancer cure must not be hostage to Big Pharma

Cancer cure must not be hostage to Big Pharma

GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India